Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong

Abstract

In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.

Keywords

• COVID-19
• SARS-CoV-2
• severe acute respiratory syndrome coronavirus 2
• viruses
• respiratory infections
• zoonoses